Third dose of COVID vaccine for immunocompromised
For the COVID-19 vaccine to protect, it must active the immune system, but in many immunocompromised patients, the ability is weakened so a third dose can boost the immune response.
For those with organ or stem cell transplants, HIV infection, steroid therapy, or certain cancer treatments, the FDA authorized the ability for them to receive a third dose of the Pfizer or Moderna vaccine.
The CDC recommends that people with moderate to severely compromised immune systems receive an additional dose at least 28 days after their second dose.
Dr. Frita Fisher, advisory board member for the National Kidney Foundation serving Mississippi, Alabama, and Georgia, tells News 25 why it is critical that immunocompromised patients receive the COVID vaccination. “We also have data to show us that those two vaccinations with the messenger RNA, Moderna and Pfizer, even though the general population did very well with just two doses, we see that many immunocompromised patients and patients that have had transplants, they just did not mount the same immune response. So, in the research studies, we saw that a third dose allowed them to mount a better immunity.”
Those who are immunocompromised should consult with their physician before getting the third dose of the COVID vaccine.